Approval · Notice of Compliance 10160 · 2009
CLASTEON: Notice of Compliance 10160
Issued April 17, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10160
- Date
- April 17, 2009
- Company
- Sepracor Pharmaceuticals IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Bone metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLASTEON | 02245829 | — |
| CLASTEON | 02245828 | Marketed |
Medicinal ingredients
- CLODRONATE DISODIUM 30 MG per ML
- CLODRONATE DISODIUM 400 MG per CAP